Product Information
VALPROIC ACID 250 MG CAPSULE is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.2426 per EA under NDC 00832031011. Its NADAC has been published 600 times since Apr 8, 2015.
FDA first approved this application on Oct 29, 1991. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832031011
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VALPROIC ACIDApproval Type
Generic (ANDA)
FDA Application
ANDA073229FDA Approved
10/29/1991
TE Code
AB
On Market Since
10/29/2011
Pharmacological Classes
Price Statistics
The NADAC for VALPROIC ACID 250 MG CAPSULE has been published 600 times since Apr 8, 2015, and over the history we have for it it has risen 46.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2426 per EA |
|---|---|
| All-time high | $0.2584 (Mar 13, 2024) |
| All-time low | $0.1506 (Nov 23, 2016) |
| 52-week high | $0.2518 |
| 52-week low | $0.2337 |
| Median price | $0.2203 |
| Average price | $0.2142 |
| Largest weekly change | +31.7% (Jul 19, 2017) |
| Weeks tracked | 600 |
| Tracking since | Apr 8, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the valproic acid market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
valproic acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALPROIC ACID 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VALPROIC ACID 250 MG CAPSULE, manufactured by Upsher-Smith Laboratories LLC, is $0.2426 per EA (NDC 00832031011), effective Sep 30, 2026.
How has the price of VALPROIC ACID 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VALPROIC ACID 250 MG CAPSULE has risen 46.7%. It has been tracked across 600 weekly CMS publications since Apr 8, 2015.
What are the highest and lowest recorded NADAC prices for VALPROIC ACID 250 MG CAPSULE?
Since Apr 8, 2015, the NADAC for VALPROIC ACID 250 MG CAPSULE has ranged from a low of $0.1506 (Nov 23, 2016) to a high of $0.2584 (Mar 13, 2024), with a median of $0.2203 per EA.
Are there cheaper alternatives to VALPROIC ACID 250 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of VALPROIC ACID 250 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VALPROIC ACID 250 MG CAPSULE?
VALPROIC ACID 250 MG CAPSULE (NDC 00832031011) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.